רופילק 300

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Nunua Sasa

Viambatanisho vya kazi:

ANTI-D IMMUNOGLOBULINS

Inapatikana kutoka:

CSL BEHRING LTD., ISRAEL

ATC kanuni:

J06BB01

Dawa fomu:

תמיסה להזרקה

Tungo:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Njia ya uendeshaji:

תוך-שרירי, תוך-ורידי

Dawa ya aina:

מרשם נדרש

Viwandani na:

CSL BEHRING AG, SWITZERLAND

Kundi la matibabu:

ANTI-D (RH) IMMUNOGLOBULIN

Eneo la matibabu:

ANTI-D (RH) IMMUNOGLOBULIN

Matibabu dalili:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Idhini ya tarehe:

2023-02-28

Nyaraka katika lugha zingine

Tabia za bidhaa Tabia za bidhaa Kiingereza 13-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiingereza 08-06-2023

Tafuta arifu zinazohusiana na bidhaa hii